Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseHematopoietic Stem Cell TransplantationTransplantation, AutologousBone MarrowWhole-Body IrradiationBone Marrow CellsTransplantation ConditioningHematopoiesisGraft SurvivalTransplantation ChimeraLeukemiaHematopoietic Stem CellsTissue DonorsTransplantation, IsogeneicAnemia, AplasticBusulfanGraft vs Tumor EffectLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRecurrenceHistocompatibility TestingHematologic NeoplasmsHistocompatibilityLiver TransplantationRemission InductionLeukocyte TransfusionLeukemia, Myeloid, AcuteGraft vs Leukemia EffectLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaMice, Inbred C57BLCyclophosphamideImmunosuppressive AgentsAcute DiseaseTreatment OutcomeRadiation ChimeraGraft vs Host ReactionGranulocyte Colony-Stimulating FactorLymphocyte TransfusionAntigens, CD34Transplantation ImmunologyColony-Forming Units AssayGraft RejectionT-LymphocytesCombined Modality TherapyStem Cell TransplantationLeukemia, MyeloidHepatic Veno-Occlusive DiseaseImmunosuppressionHematopoietic Stem Cell MobilizationKidney TransplantationTime FactorsMyelodysplastic SyndromesSurvival AnalysisCyclosporineNuclear FamilyBone Marrow PurgingBone and BonesRetrospective StudiesChimeraHLA AntigensCytomegalovirus InfectionsSurvival RateLymphoma, Non-HodgkinMultiple MyelomaHeart TransplantationActuarial AnalysisMice, Inbred BALB CPeripheral Blood Stem Cell TransplantationDisease-Free SurvivalAntineoplastic Combined Chemotherapy ProtocolsHematologic DiseasesFollow-Up StudiesCell SeparationFlow CytometryFatal OutcomeSevere Combined ImmunodeficiencyBlood Cell CountLung TransplantationFetal BloodCytarabineNeoplasm, ResidualSalvage TherapyLymphomaCell DifferentiationSpleenLife TablesBone Marrow DiseasesRecombinant ProteinsSkin TransplantationLymphocyte ActivationPrognosisLymphocyte Culture Test, MixedLeukocyte CountMelphalanOrgan TransplantationIsoantigensMethotrexateImmunophenotyping